A polymorphism at the 3'-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole.

BMC Cancer · 2010 · PMC2830181 · PMID 20144226

Europe PMC DOI

hedged sentence

0.1910

closest p · 3.8× alpha

0.1910

boldest claim

The sentences

did not reach statistical significancep = 0.191not close (p > 0.1)

However, in the multivariate analysis only the polymorphism rs4646 emerged as an independent prognostic factor although it did not reach statistical significance (p = 0.191).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.